# Adriakaim

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adriakaim

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: www.adriakaim.co.jp
- Total disclosed funding: $8.2M
- Latest round: Series B (Sep 13, 2021)
- Investors on record: 5

## About

Based in Tokyo, Japan, and established in 2018, Adriakaim Inc. engages in business of planning, research, design, development, manufacturing and sales of medical and health-related equipment. The company carried out fundraising in 2019, 2020 and 2021. They also provide consulting service in medical and health-related equipment. 
Representative Director and President Masatoshi Kobayashi joined Olympus Optical Co., Ltd. (currently Olympus Corporation) in 1982, in 2010 became Research and Development Manager. In 2011, became General Manager of the Medical Technology Development Division. In 2017. became office manager of the Innovation Promotion Office. In 2018, he co-founded Adriakaim, Inc. Director Hiroyuki Imabayashi joined
Olympus Optical Co., Ltd. in 1987, as medical device, bio-related device development leader. In 2018, he later co-founded Adriakaim. 

The company is developing innovative medical devices for use in the field of heart disease medicine. Adriakaim aims to suppress the onset of chronic heart failure through application of a vagus nerve stimulation device.

## Funding rounds

- Series B, Sep 13, 2021, $3.9M — 360ip, CEJ Capital
- Series B, Aug 4, 2020, $2.8M — UTokyo Innovation Platform
- Series A, Nov 18, 2019, $1.5M — Mitsubishi UFJ Capital, Capital Medica Ventures

## Investors

- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series A
- Capital Medica Ventures (https://capitalatlas.ai/funds/capital-medica-ventures) — Series A
- UTokyo Innovation Platform (https://capitalatlas.ai/funds/utokyo-innovation-platform) — Series B
- 360ip (https://capitalatlas.ai/funds/360ip) — Series B
- CEJ Capital (https://capitalatlas.ai/funds/cej-capital) — Series B